- World rank, 2022–2025
- #23,523 of 28,054 · #23,456 all time
- Rank in United States
- #3,526 of 4,192
- Research works
- 246 ▲ 73% vs 2013–17
- Citations
- 3.8k 15.6 per fractional work
- Top-10% rate
- 22.2% record average 16.5%
- Open access
- 35% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 11.8×. Every wedge is a field page.
- Economics, Econometrics and Finance 11.8×
- Medicine 2.0×
- Pharmacology, Toxicology and Pharmaceutics 1.8×
- Health Professions 1.8×
- Immunology and Microbiology 1.2×
- Decision Sciences 1.2×
- Biochemistry, Genetics and Molecular Biology 1.1×
- Mathematics 1.0×
- Business, Management and Accounting 1.0×
- Psychology 1.0×
- Neuroscience 0.6×
- Social Sciences 0.5×
- Arts and Humanities 0.5×
- Chemistry 0.4×
- Environmental Science 0.4×
- Agricultural and Biological Sciences 0.2×
- Computer Science 0.2×
- Nursing 0.2×
- Engineering 0.1×
- Earth and Planetary Sciences 0.1×
- Materials Science 0.1×
Who are the top researchers at Institute for Clinical and Economic Review?
Ranked on the composite score, Richard H. Chapman, David M. Rind and Steven D. Pearson lead among researchers whose main affiliation is Institute for Clinical and Economic Review.
- 1 Richard H. Chapman United States · #112,047 worldwide 647 citations · 21 works
- 2 David M. Rind United States · #124,455 worldwide 208 citations · 22 works
- 3 Steven D. Pearson United States · #159,502 worldwide 159 citations · 35 works
- 4 Daniel A. Ollendorf United States · #590,000 worldwide 81 citations · 29 works
- 5 Frank Ching United States · #1,006,775 worldwide 2 citations · 16 works
- 6 Claiborne Pell United States · #1,199,936 worldwide 0 citations · 50 works
- 7 Foluso Agboola United States · #1,417,427 worldwide 14 citations · 15 works
Which keywords describe research at Institute for Clinical and Economic Review?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Clinical Trials, Pharmaceutical Industry, Drug Development Costs, Generic Drugs and Efficacy.
- Stem Cell Regulation
- Nanoscale Science
- Convention Attendees
- Patient Safety
- Health Care Utilization
- Chronic Pain
- Environmental Policy
- Quality Improvement
- Low-Value Care
- Prognosis
- Pain Management
- Heart Failure
- Cost of Care
- Prevalence
- Hemophilia
- Gene Therapy
- Treatment
- Drug Development Costs
- Clinical Trials
- Cost-effectiveness Analysis
- Quality of Life
- Health Utility Measures
- Pharmaceutical Industry
- Generic Drugs
- Efficacy
- Factor VIII
- Patient Engagement
- Ethical Issues
- Financial Toxicity
- Neurobiology
- Health Care Costs
- Choosing Wisely
- Primary Care
- Behavior Change
- Thrombosis
- Health Care Spending
- Insurance Markets
- Comorbidity
- Economic Impacts
- Regulatory Challenges
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Quality of Life10▲ 10×4 topics
- Cost-effectiveness Analysis10▲ 163×1 topic
- Health Utility Measures10▲ 163×1 topic
- Clinical Trials4▲ 8.4×10 topics
- Pharmaceutical Industry3▲ 133×2 topics
- Drug Development Costs3▲ 171×1 topic
- Generic Drugs3▲ 171×1 topic
- Treatment2▲ 3.0×7 topics
- Efficacy2▲ 44×2 topics
- Gene Therapy2▲ 17×3 topics
- Factor VIII2▲ 195×1 topic
- Hemophilia2▲ 195×1 topic
- Patient Engagement2▲ 19×4 topics
- Prevalence2▲ 6.2×6 topics
- Ethical Issues2▲ 22×2 topics
- Cost of Care2▲ 74×1 topic
- Financial Toxicity2▲ 74×1 topic
- Heart Failure2▲ 5.0×5 topics
- Neurobiology2▲ 8.6×4 topics
- Pain Management2▲ 9.6×5 topics
- Health Care Costs1▲ 26×2 topics
- Prognosis1▲ 6.1×4 topics
- Choosing Wisely1▲ 85×1 topic
- Low-Value Care1▲ 85×1 topic
- Primary Care1▲ 4.9×2 topics
- Quality Improvement1▲ 10×2 topics
- Behavior Change1▲ 12×4 topics
- Environmental Policy1▲ 8.4×2 topics
- Thrombosis1▲ 6.3×4 topics
- Chronic Pain1▲ 7.4×3 topics
- Health Care Spending1▲ 38×1 topic
- Health Care Utilization1▲ 15×2 topics
- Insurance Markets1▲ 38×1 topic
- Patient Safety1▲ 11×2 topics
- Comorbidity1▲ 13×2 topics
- Convention Attendees1▲ 175×1 topic
- Economic Impacts1▲ 21×1 topic
- Nanoscale Science1▲ 144×1 topic
- Regulatory Challenges1▲ 17×1 topic
- Stem Cell Regulation1▲ 67×1 topic
Which research topics does Institute for Clinical and Economic Review publish most on?
By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Hemophilia Treatment and Research and Economic and Financial Impacts of Cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 10 works
- 2 Pharmaceutical Economics and Policy Economics and Econometrics 3 works
- 3 Hemophilia Treatment and Research Hematology 2 works
- 4 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
- 5 Healthcare cost, quality, practices General Health Professions 1 works
- 6 Healthcare Policy and Management Economics and Econometrics 1 works
- 7 Nanotechnology research and applications Biomedical Engineering 1 works
- 8 Climate Change Policy and Economics Economics and Econometrics 1 works
- 9 Conferences and Exhibitions Management Sociology and Political Science 1 works
- 10 Biomedical Ethics and Regulation Physiology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institute for Clinical and Economic Review's research output changed?
Output in 2018–2022 was 73% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Boston
- Boston University
- Massachusetts General Hospital
- Brigham and Women's Hospital
- Northeastern University
- Boston Children's Hospital
- Boston College
- Beth Israel Deaconess Medical Center
- General Electric (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.